Marco Ladetto
Marco Ladetto
AO ss Antonio e Biagio e Cesare Arrigo
Email verificata su
TitoloCitata daAnno
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
F Pichiorri, SS Suh, M Ladetto, M Kuehl, T Palumbo, D Drandi, C Taccioli, ...
Proceedings of the National Academy of Sciences 105 (35), 12885-12890, 2008
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
H Tilly, M Gomes da Silva, U Vitolo, A Jack, M Meignan, ...
Annals of oncology 26 (suppl_5), v116-v125, 2015
Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myeloma
M Ladetto, G Pagliano, S Ferrero, F Cavallo, D Drandi, L Santo, C Crippa, ...
Journal of Clinical Oncology 28 (12), 2077-2084, 2010
Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells
P Corradini, C Voena, I MAJOLINO, M BOCCADORO, A Pileri
Journal of Clinical Oncology 17 (1), 208-215, 1999
ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma
M Dreyling, C Thieblemont, A Gallamini, L Arcaini, E Campo, O Hermine, ...
Annals of Oncology 24 (4), 857-877, 2013
Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis …
M Ladetto, F De Marco, F Benedetti, U Vitolo, C Patti, A Rambaldi, ...
Blood 111 (8), 4004-4013, 2008
Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies
A Trojan, JL Schultze, M Witzens, RH Vonderheide, M Ladetto, ...
Nature medicine 6 (6), 667, 2000
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M Dreyling, M Ghielmini, S Rule, G Salles, U Vitolo, M Ladetto
Annals of oncology 27 (suppl_5), v83-v90, 2016
Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell …
P Corradini, M Astolfi, C Cherasco, M Ladetto, C Voena, D Caracciolo, ...
Blood 89 (2), 724-491, 1997
Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders
M Ladetto, M Brüggemann, L Monitillo, S Ferrero, F Pepin, D Drandi, ...
Leukemia 28 (6), 1299, 2014
Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP
P Pregno, A Chiappella, M Bellò, B Botto, S Ferrero, S Franceschetti, ...
Blood 119 (9), 2066-2073, 2012
Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
DA Eichenauer, A Engert, M André, M Federico, T Illidge, M Hutchings, ...
Annals of Oncology 25 (suppl_3), iii70-iii75, 2014
ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)
M Ghielmini, U Vitolo, E Kimby, S Montoto, J Walewski, M Pfreundschuh, ...
Annals of oncology 24 (3), 561-576, 2012
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies
P Corradini, C Tarella, A Olivieri, AM Gianni, C Voena, F Zallio, M Ladetto, ...
Blood 99 (1), 75-82, 2002
High-dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting
P Corradini, C Voena, M Astolfi, M Ladetto, C Tarella, M Boccadoro, ...
Blood 85 (6), 1596-1602, 1995
Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
DA Eichenauer, A Engert, M Dreyling, ESMO Guidelines Working Group
Annals of Oncology 22 (suppl_6), vi55-vi58, 2011
Immunoglobulin heavy-chain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia
JW Donovan, M Ladetto, G Zou, D Neuberg, C Poor, D Bowers, ...
Blood 95 (8), 2651-2658, 2000
Mutational activation of N-and K-ras oncogenes in plasma cell dyscrasias
P Corradini, M Ladetto, C Voena, A Palumbo, G Inghirami, DM Knowles, ...
Blood 81 (10), 2708-2713, 1993
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome
D Rossi, V Spina, M Cerri, S Rasi, C Deambrogi, L De Paoli, L Laurenti, ...
Clinical Cancer Research 15 (13), 4415-4422, 2009
Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial
U Vitolo, A Chiappella, S Franceschetti, AM Carella, I Baldi, G Inghirami, ...
The Lancet Oncology 15 (7), 730-737, 2014
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20